ATE234304T1 - Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte - Google Patents

Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte

Info

Publication number
ATE234304T1
ATE234304T1 AT97928473T AT97928473T ATE234304T1 AT E234304 T1 ATE234304 T1 AT E234304T1 AT 97928473 T AT97928473 T AT 97928473T AT 97928473 T AT97928473 T AT 97928473T AT E234304 T1 ATE234304 T1 AT E234304T1
Authority
AT
Austria
Prior art keywords
group
production
intermediate products
derivatives
duocarmycin
Prior art date
Application number
AT97928473T
Other languages
English (en)
Inventor
Yasumichi Fukuda
Shiro Terashima
Original Assignee
Kyorin Seiyaku Kk
Sagami Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk, Sagami Chem Res filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE234304T1 publication Critical patent/ATE234304T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97928473T 1996-09-18 1997-06-26 Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte ATE234304T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8246097A JPH1087666A (ja) 1996-09-18 1996-09-18 デュオカルマイシンsa及びその誘導体の製造中間体と製造方法
PCT/JP1997/002207 WO1998012197A1 (en) 1996-09-18 1997-06-26 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates

Publications (1)

Publication Number Publication Date
ATE234304T1 true ATE234304T1 (de) 2003-03-15

Family

ID=17143451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928473T ATE234304T1 (de) 1996-09-18 1997-06-26 Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte

Country Status (10)

Country Link
US (1) US6066742A (de)
EP (1) EP0937726B1 (de)
JP (1) JPH1087666A (de)
KR (1) KR20000036211A (de)
CN (1) CN1090632C (de)
AT (1) ATE234304T1 (de)
AU (1) AU3274997A (de)
CA (1) CA2266505A1 (de)
DE (1) DE69719781D1 (de)
WO (1) WO1998012197A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2260570T3 (es) 1998-08-27 2006-11-01 Spirogen Limited Pirrolobenziodiazepinas dimericas.
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
US6909006B1 (en) * 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
KR20030033007A (ko) * 2001-05-31 2003-04-26 코울터 파머수티컬, 인코포레이티드 세포독소, 약물전구체, 링커 및 이에 유용한 안정화제
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
US7691962B2 (en) * 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
BRPI0510909A2 (pt) * 2004-05-19 2008-12-16 Medarex Inc composto de ligaÇço fÁrmaco-ligante citotàxico, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula e mÉtodo para retardar ou interromper o crescimento de tumor
ES2386366T3 (es) * 2005-02-18 2012-08-17 Medarex, Inc. Anticuerpo monoclonal humano contra el antígeno de membrana específico de la próstata (PSMA)
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
EA016577B1 (ru) * 2005-09-26 2012-06-29 Медарекс, Инк. Конъюгаты антитело-лекарство и их применение
BRPI0619331A2 (pt) 2005-10-26 2011-09-27 Medarex Inc método para fazer um composto para preparar um análogo de cbi cc-1065, método para preparar um análogo de cbi cc-1065 e composto
WO2007059404A2 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
RU2320662C1 (ru) * 2006-08-24 2008-03-27 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ ПИРРОЛО[4,3-b]ИНДОЛЫ, КОМБИНАТОРНАЯ И ФОКУСИРОВАННАЯ БИБЛИОТЕКИ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
TWI412367B (zh) 2006-12-28 2013-10-21 梅達雷克斯有限責任公司 化學鏈接劑與可裂解基質以及其之綴合物
JP2010519310A (ja) 2007-02-21 2010-06-03 メダレックス インコーポレイテッド 単一のアミノ酸を有する化学リンカーおよびその複合体
AR080154A1 (es) 2010-02-10 2012-03-14 Immunogen Inc Anticuerpos cd20 y su utilizacion
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. 荷電連結体及び共役体のためのその使用
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648313B2 (en) * 1990-04-25 1994-04-21 Pharmacia & Upjohn Company Novel CC-1065 analogs
JP3037965B2 (ja) * 1990-06-20 2000-05-08 財団法人相模中央化学研究所 2―アルコキシカルボニル―2―メチル―1―オキソ―1,2,3,6,7,8―ヘキサヒドロ―ベンゾ〔1,2―b;4,3―b´〕ジピロール誘導体
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
JPH06116270A (ja) * 1992-08-21 1994-04-26 Kyorin Pharmaceut Co Ltd テトラヒドロピロロインドール誘導体及びその製法並びにその中間体

Also Published As

Publication number Publication date
WO1998012197A1 (en) 1998-03-26
DE69719781D1 (de) 2003-04-17
US6066742A (en) 2000-05-23
CN1090632C (zh) 2002-09-11
AU3274997A (en) 1998-04-14
EP0937726A1 (de) 1999-08-25
EP0937726B1 (de) 2003-03-12
JPH1087666A (ja) 1998-04-07
EP0937726A4 (de) 2001-04-11
KR20000036211A (ko) 2000-06-26
CA2266505A1 (en) 1998-03-26
CN1230960A (zh) 1999-10-06

Similar Documents

Publication Publication Date Title
DE69719781D1 (de) Zwischenprodukte zur Herstellung von Duocarmycin SA und dessen Derivaten sowie ein Verfahren zur Herstellung der Zwischenprodukte
DE69415319D1 (de) Verfahren zur herstellung von piperidinderivaten
IS6257A (is) Frumuviðloðunartálmar
DE69112989D1 (de) Aminocoumaranderivate, ihre Herstellung und Verwendung.
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
ATE104145T1 (de) 4-substituierten imidazolen zur senkung des intraokularen druckes.
DE3869173D1 (de) Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
ATE325788T1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
DE69527787D1 (de) Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
ATE208381T1 (de) Verfahren zur herstellung von taxol und seiner derivate
AU655869B2 (en) An amphoteric tricyclic compound
DE59709792D1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
ATE401303T1 (de) Verfahren zur herstellung von ed-71
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
EP0802179A4 (de) Derivate substituierter amidinonaphthylester
DE69332441D1 (de) Verfahren zur Herstellung von Halogenacetamidderivaten
ATE205178T1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3- cyclobuten-1,2-dion
ATE364600T1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
DE69533833D1 (de) Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten
DE69708640D1 (de) Pyridoncarbonsäure-derivate und zwischenverbindungen für deren herstellung
DE69608030D1 (de) Verfahren zur Herstellung von 2-Naphthamid-Derivate, und Zwischenprodukte zur Herstellung von 2-Naphthamid-Derivate
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE60308516D1 (de) Zwischenprodukte, verfahren für deren herstellung und deren gebrauch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties